2019 Q2 Form 10-Q Financial Statement
#000156459020039872 Filed on August 13, 2020
Income Statement
Concept | 2019 Q2 |
---|---|
Revenue | $10.11M |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | |
YoY Change | |
% of Gross Profit | |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | $380.0K |
YoY Change | 26.67% |
% of Gross Profit | |
Operating Expenses | |
YoY Change | |
Operating Profit | |
YoY Change | |
Interest Expense | $3.402M |
YoY Change | 66.03% |
% of Operating Profit | |
Other Income/Expense, Net | |
YoY Change | |
Pretax Income | $776.0K |
YoY Change | -27.27% |
Income Tax | $175.0K |
% Of Pretax Income | 22.55% |
Net Earnings | $607.0K |
YoY Change | -35.77% |
Net Earnings / Revenue | 6.01% |
Basic Earnings Per Share | $0.11 |
Diluted Earnings Per Share | $0.11 |
COMMON SHARES | |
Basic Shares Outstanding | 4.443M |
Diluted Shares Outstanding | 4.443M |
Balance Sheet
Concept | 2019 Q2 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $50.85M |
YoY Change | |
Cash & Equivalents | $50.34M |
Short-Term Investments | $510.0K |
Other Short-Term Assets | |
YoY Change | |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | $22.25M |
YoY Change | 33.22% |
Goodwill | $4.536M |
YoY Change | |
Intangibles | $157.0K |
YoY Change | |
Long-Term Investments | $500.0K |
YoY Change | 0.0% |
Other Assets | |
YoY Change | |
Total Long-Term Assets | |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | |
Total Long-Term Assets | |
Total Assets | $1.013B |
YoY Change | 12.1% |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $400.0K |
YoY Change | 33.33% |
Accrued Expenses | $2.700M |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $29.00M |
YoY Change | |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $3.100M |
YoY Change | 933.33% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $60.43M |
YoY Change | 300.23% |
Other Long-Term Liabilities | $8.700M |
YoY Change | 8.75% |
Total Long-Term Liabilities | $60.43M |
YoY Change | 161.62% |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $3.100M |
Total Long-Term Liabilities | $60.43M |
Total Liabilities | $925.0M |
YoY Change | 10.0% |
SHAREHOLDERS EQUITY | |
Retained Earnings | $42.39M |
YoY Change | |
Common Stock | $47.00K |
YoY Change | |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | $87.61M |
YoY Change | |
Total Liabilities & Shareholders Equity | $1.013B |
YoY Change | 12.1% |
Cashflow Statement
Concept | 2019 Q2 |
---|---|
OPERATING ACTIVITIES | |
Net Income | $607.0K |
YoY Change | -35.77% |
Depreciation, Depletion And Amortization | $380.0K |
YoY Change | 26.67% |
Cash From Operating Activities | $4.640M |
YoY Change | 29.61% |
INVESTING ACTIVITIES | |
Capital Expenditures | -$1.090M |
YoY Change | 419.05% |
Acquisitions | |
YoY Change | |
Other Investing Activities | -$12.99M |
YoY Change | -325.91% |
Cash From Investing Activities | -$14.09M |
YoY Change | -353.87% |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | 34.96M |
YoY Change | 274.71% |
NET CHANGE | |
Cash From Operating Activities | 4.640M |
Cash From Investing Activities | -14.09M |
Cash From Financing Activities | 34.96M |
Net Change In Cash | 25.51M |
YoY Change | 38.19% |
FREE CASH FLOW | |
Cash From Operating Activities | $4.640M |
Capital Expenditures | -$1.090M |
Free Cash Flow | $5.730M |
YoY Change | 51.19% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
|
296000 | ||
CY2020Q2 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
1830000 | |
CY2020Q2 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
2312000 | |
CY2020Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
4973000 | |
CY2020Q2 | us-gaap |
Foreclosed Assets
ForeclosedAssets
|
26000 | |
CY2019Q2 | pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Before Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodBeforeTax
|
9000 | |
pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Before Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodBeforeTax
|
19000 | ||
pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Before Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodBeforeTax
|
15000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
1820000 | |
us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
-1531000 | ||
us-gaap |
Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
|
3820000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
382000 | |
us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
-321000 | ||
us-gaap |
Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
|
802000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
1438000 | |
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
-1210000 | ||
us-gaap |
Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
|
3018000 | ||
CY2019Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
2039000 | |
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
2378000 | ||
us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
4153000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
2321000 | ||
us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
4139000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
369000 | |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
160000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
|
785000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
7000 | |
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
189000 | ||
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
|
23000 | ||
CY2020Q2 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
-184000 | |
us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
-1528000 | ||
us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
|
-321000 | ||
pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodTax
|
3000 | ||
CY2019Q2 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
-6000 | |
us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
57000 | ||
us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
14000 | ||
CY2019Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
2045000 | |
CY2020Q2 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax
|
-39000 | |
CY2019Q2 | pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodTax
|
2000 | |
pbhc |
Other Comprehensive Income Loss Unrealized Holding Gain Loss On Securities Transferred To Held To Maturity Arising During Period Tax
OtherComprehensiveIncomeLossUnrealizedHoldingGainLossOnSecuritiesTransferredToHeldToMaturityArisingDuringPeriodTax
|
5000 | ||
us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
3241000 | ||
us-gaap |
Interest Income Securities Taxable
InterestIncomeSecuritiesTaxable
|
3454000 | ||
CY2019Q2 | us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
51000 | |
us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
59000 | ||
us-gaap |
Interest Income Securities Tax Exempt
InterestIncomeSecuritiesTaxExempt
|
159000 | ||
CY2019Q2 | us-gaap |
Dividend Income Operating
DividendIncomeOperating
|
74000 | |
us-gaap |
Dividend Income Operating
DividendIncomeOperating
|
134000 | ||
us-gaap |
Dividend Income Operating
DividendIncomeOperating
|
151000 | ||
CY2019Q2 | us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
106000 | |
us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
49000 | ||
us-gaap |
Interest Income Federal Funds Sold
InterestIncomeFederalFundsSold
|
216000 | ||
CY2019Q2 | us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
10108000 | |
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
21557000 | ||
us-gaap |
Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
|
19777000 | ||
CY2019Q2 | us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
2740000 | |
us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
4760000 | ||
us-gaap |
Interest Expense Deposits
InterestExpenseDeposits
|
5085000 | ||
CY2019Q2 | us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
58000 | |
us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
96000 | ||
us-gaap |
Interest Expense Short Term Borrowings
InterestExpenseShortTermBorrowings
|
225000 | ||
CY2019Q2 | us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
387000 | |
us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
884000 | ||
us-gaap |
Interest Expense Long Term Debt
InterestExpenseLongTermDebt
|
780000 | ||
CY2019Q2 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
217000 | |
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
398000 | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
434000 | ||
CY2019Q2 | us-gaap |
Interest Expense
InterestExpense
|
3402000 | |
us-gaap |
Interest Expense
InterestExpense
|
6138000 | ||
us-gaap |
Interest Expense
InterestExpense
|
6524000 | ||
CY2019Q2 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
6706000 | |
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
15419000 | ||
us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
13253000 | ||
CY2019Q2 | us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
610000 | |
us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
2213000 | ||
us-gaap |
Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
|
754000 | ||
CY2019Q2 | us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
6096000 | |
us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
13206000 | ||
us-gaap |
Interest Income Expense After Provision For Loan Loss
InterestIncomeExpenseAfterProvisionForLoanLoss
|
12499000 | ||
CY2019Q2 | us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
101000 | |
us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
222000 | ||
us-gaap |
Bank Owned Life Insurance Income
BankOwnedLifeInsuranceIncome
|
222000 | ||
CY2019Q2 | us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
32000 | |
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
1049000 | ||
us-gaap |
Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
|
111000 | ||
CY2019Q2 | us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
16000 | |
us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
-916000 | ||
us-gaap |
Equity Securities Fv Ni Gain Loss
EquitySecuritiesFvNiGainLoss
|
57000 | ||
CY2019Q2 | pbhc |
Net Gains Losses On Sales Of Loans And Foreclosed Real Estate
NetGainsLossesOnSalesOfLoansAndForeclosedRealEstate
|
13000 | |
pbhc |
Net Gains Losses On Sales Of Loans And Foreclosed Real Estate
NetGainsLossesOnSalesOfLoansAndForeclosedRealEstate
|
769000 | ||
pbhc |
Net Gains Losses On Sales Of Loans And Foreclosed Real Estate
NetGainsLossesOnSalesOfLoansAndForeclosedRealEstate
|
5000 | ||
CY2019Q2 | us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
218000 | |
us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
522000 | ||
us-gaap |
Insurance Services Revenue
InsuranceServicesRevenue
|
461000 | ||
CY2019Q2 | us-gaap |
Noninterest Income
NoninterestIncome
|
1219000 | |
us-gaap |
Noninterest Income
NoninterestIncome
|
3279000 | ||
us-gaap |
Noninterest Income
NoninterestIncome
|
2312000 | ||
CY2019Q2 | us-gaap |
Salaries And Wages
SalariesAndWages
|
3454000 | |
us-gaap |
Salaries And Wages
SalariesAndWages
|
6219000 | ||
us-gaap |
Salaries And Wages
SalariesAndWages
|
7104000 | ||
CY2019Q2 | us-gaap |
Occupancy Net
OccupancyNet
|
632000 | |
us-gaap |
Occupancy Net
OccupancyNet
|
1461000 | ||
us-gaap |
Occupancy Net
OccupancyNet
|
1287000 | ||
CY2019Q2 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
587000 | |
us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1152000 | ||
us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1162000 | ||
CY2019Q2 | us-gaap |
Professional Fees
ProfessionalFees
|
380000 | |
us-gaap |
Professional Fees
ProfessionalFees
|
617000 | ||
us-gaap |
Professional Fees
ProfessionalFees
|
716000 | ||
CY2019Q2 | us-gaap |
Advertising Expense
AdvertisingExpense
|
242000 | |
us-gaap |
Advertising Expense
AdvertisingExpense
|
437000 | ||
us-gaap |
Advertising Expense
AdvertisingExpense
|
481000 | ||
CY2019Q2 | us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
130000 | |
us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
339000 | ||
us-gaap |
Federal Deposit Insurance Corporation Premium Expense
FederalDepositInsuranceCorporationPremiumExpense
|
241000 | ||
CY2019Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
100000 | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
250000 | ||
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
200000 | ||
CY2019Q2 | us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
229000 | |
us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
404000 | ||
us-gaap |
General Insurance Expense
GeneralInsuranceExpense
|
428000 | ||
CY2019Q2 | pbhc |
Community Service Activities
CommunityServiceActivities
|
144000 | |
pbhc |
Community Service Activities
CommunityServiceActivities
|
119000 | ||
pbhc |
Community Service Activities
CommunityServiceActivities
|
282000 | ||
CY2019Q2 | us-gaap |
Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
|
59000 | |
us-gaap |
Foreclosed Real Estate Expense
ForeclosedRealEstateExpense
|
35000 | ||
CY2019Q2 | us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
582000 | |
us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
970000 | ||
us-gaap |
Other Noninterest Expense
OtherNoninterestExpense
|
1053000 | ||
CY2019Q2 | us-gaap |
Noninterest Expense
NoninterestExpense
|
6539000 | |
us-gaap |
Noninterest Expense
NoninterestExpense
|
12003000 | ||
us-gaap |
Noninterest Expense
NoninterestExpense
|
13250000 | ||
CY2019Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
776000 | |
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
4482000 | ||
us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
1561000 | ||
CY2019Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
175000 | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
894000 | ||
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
426000 | ||
CY2019Q2 | us-gaap |
Profit Loss
ProfitLoss
|
601000 | |
us-gaap |
Profit Loss
ProfitLoss
|
3588000 | ||
us-gaap |
Profit Loss
ProfitLoss
|
1135000 | ||
CY2019Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
-6000 | |
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
57000 | ||
us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
14000 | ||
CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
607000 | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
3531000 | ||
us-gaap |
Net Income Loss
NetIncomeLoss
|
1121000 | ||
CY2019Q2 | us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
69000 | |
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
138000 | ||
us-gaap |
Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
|
69000 | ||
CY2019Q2 | pbhc |
Warrant Dividends Income Statement Impact
WarrantDividendsIncomeStatementImpact
|
8000 | |
pbhc |
Warrant Dividends Income Statement Impact
WarrantDividendsIncomeStatementImpact
|
15000 | ||
pbhc |
Warrant Dividends Income Statement Impact
WarrantDividendsIncomeStatementImpact
|
8000 | ||
CY2019Q2 | us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
38000 | |
us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
612000 | ||
us-gaap |
Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
|
41000 | ||
CY2019Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
492000 | |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
2766000 | ||
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
1003000 | ||
CY2019Q2 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.11 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.60 | ||
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.23 | ||
CY2019Q2 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.11 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.60 | ||
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.23 | ||
CY2019Q2 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.06 | |
us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.12 | ||
us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.12 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
-84000 | |
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
-117000 | ||
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax
|
-168000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
1759000 | |
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
760000 | ||
us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
3748000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
32000 | |
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
899000 | ||
us-gaap |
Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
111000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
1727000 | |
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
-139000 | ||
us-gaap |
Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
3637000 | ||
CY2020Q2 | us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
-184000 | |
us-gaap |
Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
-1528000 | ||
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
18000 | |
us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
24000 | ||
us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
|
37000 | ||
CY2020Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
88311000 | |
CY2020Q2 | pbhc |
Esop Shares Earned
EsopSharesEarned
|
59000 | |
CY2020Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
73000 | |
CY2020Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
1000 | |
CY2020Q2 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
279000 | |
CY2020Q2 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
69000 | |
CY2020Q2 | pbhc |
Dividends Warrant
DividendsWarrant
|
7000 | |
CY2019Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
66438000 | |
CY2019Q2 | pbhc |
Common Stock Issued During Period Value Private Placement Net Of Expenses
CommonStockIssuedDuringPeriodValuePrivatePlacementNetOfExpenses
|
3826000 | |
CY2019Q2 | pbhc |
Preferred Stock Issued During Period Value Private Placement Net Of Expenses
PreferredStockIssuedDuringPeriodValuePrivatePlacementNetOfExpenses
|
15370000 | |
CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
373000 | |
CY2019Q2 | pbhc |
Esop Shares Earned
EsopSharesEarned
|
89000 | |
CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
73000 | |
CY2019Q2 | us-gaap |
Dividends Common Stock
DividendsCommonStock
|
274000 | |
CY2019Q2 | us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
69000 | |
CY2019Q2 | pbhc |
Dividends Warrant
DividendsWarrant
|
8000 | |
CY2019Q2 | pbhc |
Distributions From Affiliates
DistributionsFromAffiliates
|
13000 | |
CY2019Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
87844000 | |
CY2020Q2 | us-gaap |
Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
|
6110 | |
CY2019Q2 | us-gaap |
Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
|
6110 | |
us-gaap |
Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
|
12221 | ||
us-gaap |
Employee Stock Ownership Plan Esop Shares Contributed To Esop
EmployeeStockOwnershipPlanESOPSharesContributedToESOP
|
12221 | ||
CY2020Q2 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
13437 | |
CY2019Q2 | us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
13436 | |
us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
13437 | ||
us-gaap |
Stock Issued During Period Shares Restricted Stock Award Gross
StockIssuedDuringPeriodSharesRestrictedStockAwardGross
|
13436 | ||
CY2020Q2 | us-gaap |
Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
|
0.06 | |
CY2019Q2 | us-gaap |
Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
|
0.06 | |
us-gaap |
Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
|
0.12 | ||
us-gaap |
Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
|
0.06 | ||
CY2020Q2 | pbhc |
Warrant Dividends Per Share Declared
WarrantDividendsPerShareDeclared
|
0.06 | |
CY2019Q2 | pbhc |
Warrant Dividends Per Share Declared
WarrantDividendsPerShareDeclared
|
0.06 | |
pbhc |
Warrant Dividends Per Share Declared
WarrantDividendsPerShareDeclared
|
0.12 | ||
pbhc |
Warrant Dividends Per Share Declared
WarrantDividendsPerShareDeclared
|
0.06 | ||
pbhc |
Accumulated Other Comprehensive Income Loss Reevaluation Of Deferred Tax Asset Valuation Allowance1
AccumulatedOtherComprehensiveIncomeLossReevaluationOfDeferredTaxAssetValuationAllowance1
|
-206000 | ||
pbhc |
Esop Shares Earned
EsopSharesEarned
|
142000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
139000 | ||
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
195000 | ||
us-gaap |
Dividends Common Stock
DividendsCommonStock
|
557000 | ||
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4344000 | ||
us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
138000 | ||
pbhc |
Dividends Warrant
DividendsWarrant
|
15000 | ||
CY2018Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
64459000 | |
pbhc |
Common Stock Issued During Period Value Private Placement Net Of Expenses
CommonStockIssuedDuringPeriodValuePrivatePlacementNetOfExpenses
|
3826000 | ||
pbhc |
Preferred Stock Issued During Period Value Private Placement Net Of Expenses
PreferredStockIssuedDuringPeriodValuePrivatePlacementNetOfExpenses
|
15370000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
373000 | ||
pbhc |
Esop Shares Earned
EsopSharesEarned
|
176000 | ||
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
146000 | ||
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
200000 | ||
us-gaap |
Dividends Common Stock
DividendsCommonStock
|
530000 | ||
us-gaap |
Dividends Preferred Stock
DividendsPreferredStock
|
69000 | ||
pbhc |
Dividends Warrant
DividendsWarrant
|
8000 | ||
pbhc |
Distributions From Affiliates
DistributionsFromAffiliates
|
13000 | ||
pbhc |
Amortization Of Operating Leases
AmortizationOfOperatingLeases
|
11000 | ||
pbhc |
Amortization Of Operating Leases
AmortizationOfOperatingLeases
|
15000 | ||
us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
40498000 | ||
us-gaap |
Proceeds From Sale Of Loans Held For Sale
ProceedsFromSaleOfLoansHeldForSale
|
48000 | ||
us-gaap |
Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
|
3790000 | ||
us-gaap |
Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
|
47000 | ||
pbhc |
Gains Losses On Real Estate Acquired Through Foreclosure
GainsLossesOnRealEstateAcquiredThroughForeclosure
|
-4000 | ||
pbhc |
Gains Losses On Real Estate Acquired Through Foreclosure
GainsLossesOnRealEstateAcquiredThroughForeclosure
|
0 | ||
us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
773000 | ||
us-gaap |
Gain Loss On Sales Of Loans Net
GainLossOnSalesOfLoansNet
|
5000 | ||
pbhc |
Payments For Proceeds From Sale Of Available For Sale Securities Debt
PaymentsForProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
1014000 | ||
pbhc |
Payments For Proceeds From Sale Of Available For Sale Securities Debt
PaymentsForProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
111000 | ||
us-gaap |
Heldtomaturity Securities Sold Security Realized Gain Loss Excluding Other Than Temporary Impairments
HeldtomaturitySecuritiesSoldSecurityRealizedGainLossExcludingOtherThanTemporaryImpairments
|
35000 | ||
us-gaap |
Heldtomaturity Securities Sold Security Realized Gain Loss Excluding Other Than Temporary Impairments
HeldtomaturitySecuritiesSoldSecurityRealizedGainLossExcludingOtherThanTemporaryImpairments
|
0 | ||
us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
-916000 | ||
us-gaap |
Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
|
57000 | ||
us-gaap |
Depreciation
Depreciation
|
824000 | ||
us-gaap |
Depreciation
Depreciation
|
744000 | ||
pbhc |
Amortization Accretion Of Mortgage Servicing Rights
AmortizationAccretionOfMortgageServicingRights
|
-298000 | ||
pbhc |
Amortization Accretion Of Mortgage Servicing Rights
AmortizationAccretionOfMortgageServicingRights
|
2000 | ||
pbhc |
Amortization Accretion Of Deferred Loan Costs
AmortizationAccretionOfDeferredLoanCosts
|
137000 | ||
pbhc |
Amortization Accretion Of Deferred Loan Costs
AmortizationAccretionOfDeferredLoanCosts
|
128000 | ||
pbhc |
Amortization Of Financing Cost From Subordinated Debt
AmortizationOfFinancingCostFromSubordinatedDebt
|
17000 | ||
pbhc |
Amortization Of Financing Cost From Subordinated Debt
AmortizationOfFinancingCostFromSubordinatedDebt
|
17000 | ||
pbhc |
Bank Owned Life Insurance Income Operating Activities
BankOwnedLifeInsuranceIncomeOperatingActivities
|
222000 | ||
pbhc |
Bank Owned Life Insurance Income Operating Activities
BankOwnedLifeInsuranceIncomeOperatingActivities
|
222000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
637000 | ||
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
618000 | ||
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
8000 | ||
us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
8000 | ||
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
281000 | ||
us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
322000 | ||
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
1261000 | ||
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
271000 | ||
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
1363000 | ||
us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
-14000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
40321000 | ||
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3078000 | ||
pbhc |
Payments To Acquire Available For Sale Debt And Equity Securities
PaymentsToAcquireAvailableForSaleDebtAndEquitySecurities
|
79052000 | ||
pbhc |
Payments To Acquire Available For Sale Debt And Equity Securities
PaymentsToAcquireAvailableForSaleDebtAndEquitySecurities
|
12280000 | ||
us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
39552000 | ||
us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
46970000 | ||
us-gaap |
Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
|
1176000 | ||
us-gaap |
Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
|
2605000 | ||
CY2019Q4 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
781341000 | |
us-gaap |
Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
|
1919000 | ||
us-gaap |
Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
|
61781000 | ||
pbhc |
Increase Decrease In Brokered Deposits
IncreaseDecreaseInBrokeredDeposits
|
28085000 | ||
pbhc |
Increase Decrease In Brokered Deposits
IncreaseDecreaseInBrokeredDeposits
|
34088000 | ||
us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-14980000 | ||
us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
-10000000 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
18060000 | ||
us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
19100000 | ||
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
15312000 | ||
us-gaap |
Proceeds From Sale Of Federal Home Loan Bank Stock
ProceedsFromSaleOfFederalHomeLoanBankStock
|
4099000 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
47457000 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
|
12044000 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
19523000 | ||
us-gaap |
Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
|
5035000 | ||
pbhc |
Proceeds From Sale Of Available For Sale Debt And Equity Securities
ProceedsFromSaleOfAvailableForSaleDebtAndEquitySecurities
|
24768000 | ||
pbhc |
Proceeds From Sale Of Available For Sale Debt And Equity Securities
ProceedsFromSaleOfAvailableForSaleDebtAndEquitySecurities
|
63486000 | ||
us-gaap |
Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
|
1589000 | ||
us-gaap |
Proceeds From Sale Of Held To Maturity Securities
ProceedsFromSaleOfHeldToMaturitySecurities
|
548000 | ||
us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
116000 | ||
us-gaap |
Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
|
1085000 | ||
us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
61017000 | ||
us-gaap |
Payments For Proceeds From Loans And Leases
PaymentsForProceedsFromLoansAndLeases
|
73419000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
436000 | ||
us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
2368000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-85861000 | ||
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-51345000 | ||
us-gaap |
Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
|
100069000 | ||
us-gaap |
Increase Decrease In Demand Deposits
IncreaseDecreaseInDemandDeposits
|
-14292000 | ||
us-gaap |
Increase Decrease In Time Deposits
IncreaseDecreaseInTimeDeposits
|
-39454000 | ||
us-gaap |
Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
|
0 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
195000 | ||
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
200000 | ||
us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
567000 | ||
us-gaap |
Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
|
526000 | ||
us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
139000 | ||
us-gaap |
Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
|
0 | ||
pbhc |
Payments Of Dividends Warrants
PaymentsOfDividendsWarrants
|
15000 | ||
pbhc |
Payments Of Dividends Warrants
PaymentsOfDividendsWarrants
|
0 | ||
pbhc |
Proceeds From Finance Lease Transaction
ProceedsFromFinanceLeaseTransaction
|
0 | ||
pbhc |
Proceeds From Finance Lease Transaction
ProceedsFromFinanceLeaseTransaction
|
572000 | ||
us-gaap |
Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
|
57000 | ||
us-gaap |
Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
|
1000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
70503000 | ||
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
72293000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
24963000 | ||
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
24026000 | ||
CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
45123000 | |
CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
50342000 | |
us-gaap |
Interest Paid Net
InterestPaidNet
|
6259000 | ||
us-gaap |
Interest Paid Net
InterestPaidNet
|
6382000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
550000 | ||
us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | ||
pbhc |
Transfer Of Loans To Foreclosed Real Estate
TransferOfLoansToForeclosedRealEstate
|
58000 | ||
pbhc |
Transfer Of Loans To Foreclosed Real Estate
TransferOfLoansToForeclosedRealEstate
|
503000 | ||
pbhc |
Collateral Deposits For Hedge Position Included In Interest Earning Deposits
CollateralDepositsForHedgePositionIncludedInInterestEarningDeposits
|
1600000 | ||
pbhc |
Collateral Deposits For Hedge Position Included In Interest Earning Deposits
CollateralDepositsForHedgePositionIncludedInInterestEarningDeposits
|
0 | ||
us-gaap |
Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note 2: New Accounting Pronouncements</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Financial Accounting Standards Board (“FASB”) and, to a lesser extent, other authoritative rulemaking bodies promulgate generally accepted accounting principles (“GAAP”) to regulate the standards of accounting in the United States. From time to time, the FASB issues new GAAP standards, known as Accounting Standards Updates (“ASUs”) some of which, upon adoption, may have the potential to change the way in which the Company recognizes or reports within its consolidated financial statements. <font style="color:#000000;">The following table provides a description of the accounting standards that are not currently effective, but could have an impact on the Company's consolidated financial statements upon adoption. </font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;"> </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td colspan="7" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:100%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standards Not Yet Adopted as of June 30, 2020</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Measurement of Credit Losses on Financial Instruments <font style="font-style:italic;">(ASU 2016-13: Financial Instruments—Credit Losses [Topic 326]: Measurement of Credit Losses on Financial Instruments)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amended guidance replaces the current incurred loss model for determining the allowance for credit losses. The guidance requires financial assets measured at amortized cost to be presented at the net amount expected to be collected. The allowance for credit losses will represent a valuation account that is deducted from the amortized cost basis of the financial assets to present their net carrying value at the amount expected to be collected. The income statement will reflect the measurement of credit losses for newly recognized financial assets as well as expected increases or decreases of expected credit losses that have taken place during the period. When determining the allowance, expected credit losses over the contractual term of the financial asset(s) (taking into account prepayments) will be estimated considering relevant information about past events, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The amended guidance also requires recording an allowance for credit losses for purchased financial assets with a more-than-insignificant amount of credit deterioration since origination. The initial allowance for these assets will be added to the purchase price at acquisition rather than being reported as an expense. Subsequent changes in the allowance will be recorded through the income statement as an expense adjustment. In addition, the amended guidance requires credit losses relating to available-for-sale debt securities to be recorded through an allowance for credit losses. The calculation of credit losses for available-for-sale securities will be similar to how it is determined under existing guidance.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2023 (early adoption permitted as of January 1, 2019)</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is assessing the new guidance to determine what modifications to existing credit estimation processes may be required. The new guidance is complex and management is still evaluating the preliminary output from models that have been developed during this evaluative phase. In addition, future levels of allowances will also reflect new requirements to include estimated credit losses on investment securities classified as held-to-maturity, if any. The Company has formed an Implementation Committee, whose membership includes representatives of senior management, to develop plans that will encompass: (1) internal methodology changes (2) data collection and management activities, (3) internal communication requirements, and (4) estimation of the projected impact of this guidance. It has been generally assumed that the conversion from the incurred loss model, required under current GAAP, to the current expected credit loss (CECL) methodology (as required upon implementation of this Update) will, more likely than not, result in increases to the allowances for credit losses at many financial institutions. However, the amount of any change in the allowance for credit losses resulting from the new guidance will ultimately be impacted by the provisions of this guidance as well as by the loan and debt security portfolios composition and asset quality at the adoption date, and economic conditions and forecasts at the time of adoption. The amendments in this Update should be applied on a modified retrospective basis by means of a cumulative-effect adjustment to the opening retained earnings balance in the statement of financial position as of the date that an entity adopted the amendments in Update 2016-13. The cumulative impact of the economic effects of the COVID-19 pandemic on the changes to the allowance for loan losses, that will be required upon the implementation of the CECL methodology, can not be estimated at this time.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Transition Relief for the Implementation of ASU-2016-13 <font style="font-style:italic;">(ASU 2019-5: Financial Instruments—Credit Losses [Topic 326]: Targeted Transition Relief)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this ASU provide entities that have certain instruments within the scope of Subtopic 326-20, <font style="font-style:italic;">Financial Instruments—Credit Losses—Measured at Amortized Cost</font>, with an option to irrevocably elect the fair value option in Subtopic 825-10, <font style="font-style:italic;">Financial Instruments—Overall</font>, applied on an instrument-by-instrument basis for eligible instruments, upon adoption of Topic 326. The fair value option election does not apply to held-to-maturity debt securities. An entity that elects the fair value option should subsequently apply the guidance in Subtopics 820-10, <font style="font-style:italic;">Fair Value Measurement—Overall</font>, and 825-10. General guidance for the use of the fair value option is contained in Subtopic 825-10. The irrevocable election of the fair value option must be applied on an instrument-by-instrument basis for eligible instruments, whose characteristics are within the scope of Subtopic 326-20. Upon adoption of Topic 326, for items measured at fair value in accordance with paragraph 326-10-65-1(i), the difference between the carrying amount and the fair value shall be recorded by means of a cumulative-effect adjustment to the opening retained earnings balance as of the beginning of the first reporting period that an entity has adopted ASU 2016-13. Those differences may include, but are not limited to: (1) unamortized deferred costs, fees, premiums, and discounts (2) valuation allowances (for example, allowance for loan losses), or (3) accrued interest.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See comments above related to ASU 2016-13.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See comments above related to ASU 2016-13.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation<font style="font-style:italic;"> (ASU 2018-14: Compensation - Retirement Benefits - Defined Benefit Plans - General [Subtopic 715 – 20]: Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FASB is issuing the amendments in this ASU as part of the disclosure framework project. The amendments in this ASU modify the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following disclosure requirements are removed from Subtopic 715-20:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. The amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. The amount and timing of plan assets expected to be returned to the employer.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Related party disclosures about the amount of future annual benefits covered by insurance and annuity contracts and significant transactions between the employer or related parties and the plan.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. The effects of a one-percentage-point change in assumed health care cost trend rates on the (a) aggregate of the service and interest cost components of net periodic benefit costs and (b) benefit obligation for postretirement health care benefits.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following disclosure requirements are added to Subtopic 715-20:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. The weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. An explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this ASU also clarify the disclosure requirements in paragraph 715-20-50-3, which state that the following information for defined benefit pension plans should be disclosed:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. The projected benefit obligation (PBO) and fair value of plan assets for plans with PBOs in excess of plan assets.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. The accumulated benefit obligation (ABO) and fair value of plan assets for plans with ABOs in excess of plan assets.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this ASU are effective for fiscal years ending after December 15, 2020, for public business entities and for fiscal years ending after December 15, 2021, for all other entities. Early adoption is permitted for all entities.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company does not expect the new guidance will have a material impact to its consolidated statements of condition or income.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Investments <font style="font-style:italic;">(ASU 2020-01- Equity Securities [Topic 321], Investments—Equity Method and Joint Ventures [Topic 323], and Derivatives and Hedging [Topic 815]—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update clarify the interaction of the accounting for equity securities under Topic 321 and investments accounted for under the equity method of accounting in Topic 323 and the accounting for certain forward contracts and purchased options accounted for under Topic 815. The amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. The amendments clarify that for the purpose of applying paragraph 815-10-15-141(a) an entity should not consider whether, upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in Topic 323 or the fair value option in accordance with the financial instruments guidance in Topic 825. An entity also would evaluate the remaining characteristics in paragraph 815-10-15-141 to determine the accounting for those forward contracts and purchased options.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this ASU are effective for fiscal years ending after December 15, 2020, for public business entities and for fiscal years ending after December 15, 2021, for all other entities. Early adoption is permitted for all entities.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update should be applied prospectively. The Company does not expect the new guidance will have a material impact to its consolidated statements of condition or income.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes <font style="font-style:italic;">(ASU 2019-12- Simplifying the Accounting for Income Taxes)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The FASB Board is issuing this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative).</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update simplify the accounting for income taxes by removing the following exceptions, among others not considered to be applicable to the Company:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. Exception to the incremental approach for intraperiod tax allocation when there is a loss from continuing operations and income or a gain from other items (for example, discontinued operations or other comprehensive income)</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Exception to the general methodology for calculating income taxes in an interim period when a year-to-date loss exceeds the anticipated loss for the year.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update also simplify the accounting for income taxes by doing the following:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. Requiring that an entity recognize a franchise tax (or similar tax) that is partially based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Requiring that an entity evaluate when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Specifying that an entity is not required to allocate the consolidated amount of current and deferred tax expense to a legal entity that is not subject to tax in its separate financial statements. However, an entity may elect to do so (on an entity-by-entity basis) for a legal entity that is both not subject to tax and disregarded by the taxing authority.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. Requiring that an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation in the interim period that includes the enactment date.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. Making minor Codification improvements for income taxes related to employee stock ownership plans and investments in qualified affordable housing projects accounted for using the equity method.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this ASU are effective for fiscal years ending after December 15, 2020, for public business entities and for fiscal years ending after December 15, 2021, for all other entities. Early adoption of the amendments is permitted, including adoption in any interim period for (1) public business entities for periods for which financial statements have not yet been issued and (2) all other entities for periods for which financial statements have not yet been made available for issuance. An entity that elects to early adopt the amendments in an interim period should reflect any adjustments as of the beginning of the annual period that includes that interim period. Additionally, an entity that elects early adoption must adopt all the amendments in the same period.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update related to separate financial statements of legal entities that are not subject to tax should be applied on a retrospective basis for all periods presented. The amendments related to changes in ownership of foreign equity method investments or foreign subsidiaries should be applied on a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. The amendments related to franchise taxes that are partially based on income should be applied on either a retrospective basis for all periods presented or a modified retrospective basis through a cumulative-effect adjustment to retained earnings as of the beginning of the fiscal year of adoption. All other amendments should be applied on a prospective basis. The Company does not expect the new guidance will have a material impact to its consolidated statements of condition or income.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial Instruments—Credit Losses <font style="font-style:italic;">(ASU 2019-11- Codification Improvements to Topic 326)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 16, 2016, the FASB issued Accounting Standards Update No. 2016-13, <font style="font-style:italic;">Financial Instruments—Credit Losses (Topic 326)</font>: Measurement of Credit Losses on Financial Instruments, which introduced an expected credit loss model for the impairment of financial assets measured at amortized cost basis. That model replaces the probable, incurred loss model for those assets. Through the amendments in that Update, the Board added Topic 326, <font style="font-style:italic;">Financial Instruments—Credit Losses</font>, and made several consequential amendments to the Codification. The Board has an ongoing project on its agenda for improving the Codification or correcting its unintended application. The items addressed in that project generally are not expected to have a significant effect on current accounting practice or create a significant administrative cost for most entities. The amendments in this Update are similar to those items. However, the Board decided to issue a separate Update for improvements to the amendments in Update 2016-13 to increase stakeholder awareness of those amendments and to expedite the improvement process. The amendments include items brought to the Board's attention by stakeholders.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update clarify or address stakeholders' specific issues about certain aspects of the amendments in Update 2016-13 as described below:</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1. Expected Recoveries for Purchased Financial Assets with Credit Deterioration (PCDs): The amendments clarify that the allowance for credit losses for PCD assets should include in the allowance for credit losses expected recoveries of amounts previously written off and expected to be written off by the entity and should not exceed the aggregate of amounts of the amortized cost basis previously written off and expected to be written off by an entity. In addition, the amendments clarify that when a method other than a discounted cash flow method is used to estimate expected credit losses, expected recoveries should not include any amounts that result in an acceleration of the noncredit discount. An entity may include increases in expected cash flows after acquisition.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2. Transition Relief for Troubled Debt Restructurings (TDRs): The amendments provide transition relief by permitting entities an accounting policy election to adjust the effective interest rate on existing TDRs using prepayment assumptions on the date of adoption of Topic 326 rather than the prepayment assumptions in effect immediately before the restructuring.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3. Disclosures Related to Accrued Interest Receivables: The amendments extend the disclosure relief for accrued interest receivable balances to additional relevant disclosures involving amortized cost basis.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4. Financial Assets Secured by Collateral Maintenance Provisions: The amendments clarify that an entity should assess whether it reasonably expects the borrower will be able to continually replenish collateral securing the financial asset to apply the practical expedient. The amendments clarify that an entity applying the practical expedient should estimate expected credit losses for any difference between the amount of the amortized cost basis that is greater than the fair value of the collateral securing the financial asset (that is, the unsecured portion of the amortized cost basis). An entity may determine that the expectation of nonpayment for the amount of the amortized cost basis equal to the fair value of the collateral securing the financial asset is zero.</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5. Conforming Amendment to Subtopic 805-20: The amendment to Subtopic 805-20, <font style="font-style:italic;">Business Combinations—Identifiable Assets and Liabilities, and Any Noncontrolling Interest</font>, clarifies the guidance by removing the cross-reference to Subtopic 310-30 in paragraph 805-20-50-1 and replacing it with a cross-reference to the guidance on PCD assets in Subtopic 326-20.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2023 (early adoption permitted as of January 1, 2019). The effective dates and transition requirements for the amendments are the same as the effective dates and transition requirements in Update 2016-13.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is assessing the new guidance to determine what modifications to existing credit estimation processes may be required. The new guidance is complex and management is still evaluating the preliminary output from models that have been developed during this evaluative phase. In addition, future levels of allowances will also reflect new requirements to include estimated credit losses on investment securities classified as held-to-maturity, if any. The Company has formed an Implementation Committee, whose membership includes representatives of senior management, to develop plans that will encompass: (1) internal methodology changes (2) data collection and management activities, (3) internal communication requirements, and (4) estimation of the projected impact of this guidance. It has been generally assumed that the conversion from the incurred loss model, required under current GAAP, to the CECL methodology will, more likely than not, result in increases to the allowances for credit losses at many financial institutions. However, the amount of any change in the allowance for credit losses resulting from the new guidance will ultimately be impacted by the provisions of this guidance as well as by the loan and debt security portfolios composition and asset quality at the adoption date, and economic conditions and forecasts at the time of adoption. The amendments in this Update should be applied on a modified retrospective basis by means of a cumulative-effect adjustment to the opening retained earnings balance in the statement of financial position as of the date that an entity adopted the amendments in Update 2016-13.</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Standard</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Required Date</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Implementation</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect on Consolidated Financial Statements</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reference Rate Reform <font style="font-style:italic;">(ASU 2020-04- Facilitation of the Effects of Reference Rate Reform on Financial Reporting)</font></p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.34%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments provide optional expedients and exceptions for applying generally accepted accounting principles (GAAP) to contracts, hedging relationships, and other transactions affected by reference rate reform. The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The amendments (1) apply to contract modifications that replace a reference rate affected by reference rate reform, (2) provide exceptions to existing guidance related to changes to the critical terms of a hedging relationship due to reference rate reform (3) provide optional expedients for fair value hedging relationships, cash flow hedging relationships, and net investment hedging relationships, and (4) provide a onetime election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate reform and that are classified as held to maturity before January 1, 2020.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments in this Update are effective for all entities as of March 12, 2020 through December 31, 2022.</p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.02%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.18%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amendments for contract modifications can be elected to be applied as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020. The amendments for existing hedging relationships can be elected to be applied as of the beginning of the interim period that includes March 12, 2020 and to new eligible hedging relationships entered into after the beginning of the interim period that includes March 12, 2020. The Company does not expect that the guidance will have a material effect on its on its consolidated statements of condition or income.</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> | ||
CY2020Q2 | pbhc |
Consolidation Of Membership Interest In Subsidiary
ConsolidationOfMembershipInterestInSubsidiary
|
1.00 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
480000 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
773000 | |
CY2019Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
110928000 | |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
4623000 | ||
CY2020Q2 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
206000 | |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
111221000 | |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4623000 | ||
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
4344000 | ||
CY2020Q2 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
116358000 | |
CY2020Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
815000 | |
CY2020Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1248000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
115925000 | |
CY2020Q2 | pbhc |
Equity Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
|
0 | |
CY2020Q2 | pbhc |
Equity Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
|
0 | |
CY2020Q2 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
206000 | |
CY2020Q2 | pbhc |
Available For Sale Debt And Equity Securities Amortized Cost
AvailableForSaleDebtAndEquitySecuritiesAmortizedCost
|
116564000 | |
CY2020Q2 | pbhc |
Available For Sale Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
815000 | |
CY2020Q2 | pbhc |
Available For Sale Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
1248000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
2952000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
1110000 | |
CY2019Q4 | us-gaap |
Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
|
206000 | |
CY2019Q4 | pbhc |
Equity Securities Available For Sale Accumulated Gross Unrealized Gain Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainBeforeTax
|
0 | |
CY2019Q4 | pbhc |
Equity Securities Available For Sale Accumulated Gross Unrealized Loss Before Tax
EquitySecuritiesAvailableForSaleAccumulatedGrossUnrealizedLossBeforeTax
|
0 | |
CY2019Q4 | us-gaap |
Equity Securities Fv Ni
EquitySecuritiesFvNi
|
206000 | |
CY2019Q4 | pbhc |
Available For Sale Debt And Equity Securities Amortized Cost
AvailableForSaleDebtAndEquitySecuritiesAmortizedCost
|
111427000 | |
CY2019Q4 | pbhc |
Available For Sale Debt And Equity Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtAndEquitySecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
480000 | |
CY2019Q4 | pbhc |
Available For Sale Debt And Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtAndEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
773000 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
|
1393000 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
|
233000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
|
15701000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
|
8462000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
|
15309000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
|
19482000 | |
CY2020Q2 | pbhc |
Aggregate Of Available For Sale Securities Debt Maturities Amortized Cost Basis
AggregateOfAvailableForSaleSecuritiesDebtMaturitiesAmortizedCostBasis
|
58954000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
|
15701000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
8535000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
15257000 | |
CY2020Q2 | us-gaap |
Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
|
19247000 | |
CY2020Q2 | pbhc |
Aggregate Of Available For Sale Securities Debt Maturities Fair Value
AggregateOfAvailableForSaleSecuritiesDebtMaturitiesFairValue
|
58740000 | |
CY2020Q2 | pbhc |
Available For Sale Securities Debt Maturities Fair Value Net
AvailableForSaleSecuritiesDebtMaturitiesFairValueNet
|
115925000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
|
1976000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
|
17572000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After Five Through Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsNetCarryingAmount
|
20392000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After Ten Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsNetCarryingAmount
|
19316000 | |
CY2020Q2 | pbhc |
Aggregate Of Held To Maturity Securities Debt Maturities Carrying Amount
AggregateOfHeldToMaturitySecuritiesDebtMaturitiesCarryingAmount
|
59256000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
|
1999000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
|
17804000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After Five Through Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
|
20801000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Debt Maturities After Ten Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterTenYearsFairValue
|
18882000 | |
CY2020Q2 | pbhc |
Aggregate Of Held To Maturity Securities Debt Maturities Fair Value
AggregateOfHeldToMaturitySecuritiesDebtMaturitiesFairValue
|
59486000 | |
CY2020Q2 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions Less Than Twelve Months
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositionsLessThanTwelveMonths
|
26 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
894000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
33981000 | |
CY2020Q2 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions Twelve Months Or More
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositionsTwelveMonthsOrMore
|
4 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
216000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
5874000 | |
CY2020Q2 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositions
|
30 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
1110000 | |
CY2020Q2 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
39855000 | |
CY2019Q4 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions Less Than Twelve Months
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositionsLessThanTwelveMonths
|
17 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
|
226000 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
|
31395000 | |
CY2019Q4 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions Twelve Months Or More
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositionsTwelveMonthsOrMore
|
3 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
|
7000 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
|
1330000 | |
CY2019Q4 | pbhc |
Held To Maturity Number Of Securities In Unrealized Loss Positions
HeldToMaturityNumberOfSecuritiesInUnrealizedLossPositions
|
20 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Accumulated Loss
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
|
233000 | |
CY2019Q4 | us-gaap |
Held To Maturity Securities Continuous Unrealized Loss Position Fair Value
HeldToMaturitySecuritiesContinuousUnrealizedLossPositionFairValue
|
32725000 | |
CY2020Q2 | pbhc |
Total Number Of Securities Continuous Unrealized Loss Position For Twelve Months Or More
TotalNumberOfSecuritiesContinuousUnrealizedLossPositionForTwelveMonthsOrMore
|
12 | |
CY2020Q2 | pbhc |
Number Of Securities Amortized
NumberOfSecuritiesAmortized
|
4 | |
CY2020Q2 | pbhc |
Percentage Of Securities Amortized Of Total Securities
PercentageOfSecuritiesAmortizedOfTotalSecurities
|
0.629 | |
CY2020Q2 | pbhc |
Realized Gains On Investments Sold
RealizedGainsOnInvestmentsSold
|
917000 | |
CY2019Q2 | pbhc |
Realized Gains On Investments Sold
RealizedGainsOnInvestmentsSold
|
179000 | |
pbhc |
Realized Gains On Investments Sold
RealizedGainsOnInvestmentsSold
|
950000 | ||
pbhc |
Realized Gains On Investments Sold
RealizedGainsOnInvestmentsSold
|
401000 | ||
CY2020Q2 | pbhc |
Realized Losses On Sale Of Investments
RealizedLossesOnSaleOfInvestments
|
9000 | |
CY2019Q2 | pbhc |
Realized Losses On Sale Of Investments
RealizedLossesOnSaleOfInvestments
|
147000 | |
pbhc |
Realized Losses On Sale Of Investments
RealizedLossesOnSaleOfInvestments
|
16000 | ||
CY2020Q2 | pbhc |
Gain Loss On Sale Of Investments Excluding Realized Gain On Marketable Equity Security
GainLossOnSaleOfInvestmentsExcludingRealizedGainOnMarketableEquitySecurity
|
908000 | |
CY2019Q2 | pbhc |
Gain Loss On Sale Of Investments Excluding Realized Gain On Marketable Equity Security
GainLossOnSaleOfInvestmentsExcludingRealizedGainOnMarketableEquitySecurity
|
32000 | |
pbhc |
Gain Loss On Sale Of Investments Excluding Realized Gain On Marketable Equity Security
GainLossOnSaleOfInvestmentsExcludingRealizedGainOnMarketableEquitySecurity
|
934000 | ||
CY2020Q2 | pbhc |
Securities Pledged To Collateralize Deposit
SecuritiesPledgedToCollateralizeDeposit
|
98500000 | |
CY2019Q4 | pbhc |
Securities Pledged To Collateralize Deposit
SecuritiesPledgedToCollateralizeDeposit
|
92400000 | |
CY2020Q2 | pbhc |
Securities Pledged To Collateralize Borrowing
SecuritiesPledgedToCollateralizeBorrowing
|
15000000 | |
CY2019Q4 | pbhc |
Securities Pledged To Collateralize Borrowing
SecuritiesPledgedToCollateralizeBorrowing
|
21300000 | |
pbhc |
Minimum Years Of Service To Participate In Health And Life Insurance Benefits
MinimumYearsOfServiceToParticipateInHealthAndLifeInsuranceBenefits
|
P14Y | ||
CY2019Q4 | us-gaap |
Loans And Leases Receivable Deferred Income
LoansAndLeasesReceivableDeferredIncome
|
-110000 | |
pbhc |
Number Of Portfolio Segment
NumberOfPortfolioSegment
|
3 | ||
us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
185000 | ||
CY2020Q2 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
807839000 | |
pbhc |
Realized Losses On Sale Of Investments
RealizedLossesOnSaleOfInvestments
|
290000 | ||
pbhc |
Gain Loss On Sale Of Investments Excluding Realized Gain On Marketable Equity Security
GainLossOnSaleOfInvestmentsExcludingRealizedGainOnMarketableEquitySecurity
|
111000 | ||
CY2019Q4 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
7487000 | |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
7566000 | |
CY2019Q4 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
830000 | |
CY2020Q2 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
7604000 | |
CY2019Q2 | us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
6960000 | |
us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
7563000 | ||
us-gaap |
Impaired Financing Receivable Average Recorded Investment
ImpairedFinancingReceivableAverageRecordedInvestment
|
6634000 | ||
CY2020Q2 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
65000 | |
CY2019Q2 | us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
124000 | |
CY2020Q2 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
25761000 | |
CY2020Q2 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
782078000 | |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
|
16299000 | |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
|
765042000 | |
CY2020Q2 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
8385000 | |
CY2019Q4 | us-gaap |
Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
|
5246000 | |
CY2020Q2 | us-gaap |
Impaired Financing Receivable Recorded Investment
ImpairedFinancingReceivableRecordedInvestment
|
7803000 | |
CY2020Q2 | us-gaap |
Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
|
7900000 | |
CY2020Q2 | us-gaap |
Impaired Financing Receivable Related Allowance
ImpairedFinancingReceivableRelatedAllowance
|
1020000 | |
us-gaap |
Impaired Financing Receivable Interest Income Cash Basis Method
ImpairedFinancingReceivableInterestIncomeCashBasisMethod
|
130000 | ||
CY2020Q2 | us-gaap |
Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
|
536000 | |
CY2020Q2 | us-gaap |
Increase Decrease In Finance Receivables
IncreaseDecreaseInFinanceReceivables
|
113200000 | |
CY2020Q2 | pbhc |
Percentage Of Increase In Outstanding Loan Of Allowance Of Credit Loss
PercentageOfIncreaseInOutstandingLoanOfAllowanceOfCreditLoss
|
0.163 | |
CY2020Q2 | pbhc |
Percentage Of Additional Increase Of Ratio To Total Loan In Allowance Of Credit Loss
PercentageOfAdditionalIncreaseOfRatioToTotalLoanInAllowanceOfCreditLoss
|
0.0319 | |
CY2019Q2 | pbhc |
Percentage Of Additional Increase Of Ratio To Total Loan In Allowance Of Credit Loss
PercentageOfAdditionalIncreaseOfRatioToTotalLoanInAllowanceOfCreditLoss
|
0.0245 | |
CY2020Q2 | pbhc |
Allowance For Credit Losses Increase Decrease In Nonaccrual Loan
AllowanceForCreditLossesIncreaseDecreaseInNonaccrualLoan
|
4600000 | |
CY2019Q2 | pbhc |
Allowance For Credit Losses Increase Decrease In Nonaccrual Loan
AllowanceForCreditLossesIncreaseDecreaseInNonaccrualLoan
|
3800000 | |
CY2020Q2 | pbhc |
Allowance For Credit Losses Increase Decrease In Nonaccrual Loan
AllowanceForCreditLossesIncreaseDecreaseInNonaccrualLoan
|
8400000 | |
us-gaap |
Allowance For Loan And Lease Losses Period Increase Decrease
AllowanceForLoanAndLeaseLossesPeriodIncreaseDecrease
|
1500000 | ||
CY2020Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
9606000 | |
CY2020Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
208000 | |
CY2020Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
9000 | |
CY2020Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
10553000 | |
CY2020Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
1020000 | |
CY2020Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
9533000 | |
CY2020Q2 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
7803000 | |
CY2020Q2 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
800036000 | |
CY2019Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
8669000 | |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
395000 | ||
us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
66000 | ||
CY2019Q1 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
7284000 | |
CY2019Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
76000 | |
CY2019Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
7000 | |
CY2019Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
7825000 | |
CY2019Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1
FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1
|
845000 | |
CY2019Q2 | us-gaap |
Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment
FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment
|
6980000 | |
CY2019Q2 | us-gaap |
Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
|
692866000 | |
CY2019Q2 | us-gaap |
Financing Receivable Individually Evaluated For Impairment
FinancingReceivableIndividuallyEvaluatedForImpairment
|
7954000 | |
CY2019Q2 | us-gaap |
Financing Receivable Collectively Evaluated For Impairment
FinancingReceivableCollectivelyEvaluatedForImpairment
|
684912000 | |
CY2018Q4 | us-gaap |
Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
|
7306000 | |
us-gaap |
Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
|
251000 | ||
us-gaap |
Financing Receivable Allowance For Credit Losses Recovery
FinancingReceivableAllowanceForCreditLossesRecovery
|
16000 | ||
CY2020Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Specifically Reserved
FinancingReceivableAllowanceForCreditLossesSpecificallyReserved
|
1020000 | |
CY2020Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Historical Loss Rate
FinancingReceivableAllowanceForCreditLossesHistoricalLossRate
|
1399000 | |
CY2020Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Qualitative Factors
FinancingReceivableAllowanceForCreditLossesQualitativeFactors
|
7569000 | |
CY2020Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Other
FinancingReceivableAllowanceForCreditLossesOther
|
565000 | |
us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
62000 | ||
CY2019Q2 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
41000 | |
pbhc |
Reevaluation Of Deferred Tax Asset Valuation Allowance1
ReevaluationOfDeferredTaxAssetValuationAllowance1
|
-206000 | ||
us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
1528000 | ||
CY2020Q2 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
3333000 | |
CY2020Q2 | us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-643000 | |
CY2019Q2 | us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
1397000 | |
CY2019Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Specifically Reserved
FinancingReceivableAllowanceForCreditLossesSpecificallyReserved
|
845000 | |
CY2019Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Historical Loss Rate
FinancingReceivableAllowanceForCreditLossesHistoricalLossRate
|
361000 | |
CY2019Q2 | pbhc |
Financing Receivable Allowance For Credit Losses Qualitative Factors
FinancingReceivableAllowanceForCreditLossesQualitativeFactors
|
6619000 | |
CY2020Q2 | us-gaap |
Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
|
685000 | |
CY2019Q4 | us-gaap |
Mortgage Loans In Process Of Foreclosure Amount
MortgageLoansInProcessOfForeclosureAmount
|
341000 | |
CY2019Q2 | us-gaap |
Derivative Amount Of Hedged Item
DerivativeAmountOfHedgedItem
|
0 | |
CY2020Q2 | us-gaap |
Derivative Loss On Derivative
DerivativeLossOnDerivative
|
184000 | |
us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-593000 | ||
us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
-617000 | ||
us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
2975000 | ||
us-gaap |
Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
|
43000 | ||
CY2020Q2 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
33000 | |
CY2019Q2 | us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
35000 | |
us-gaap |
Noninterest Income Other
NoninterestIncomeOther
|
50000 | ||
us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
Our leases have remaining lease terms that vary from less than one year up to 31 years, some of which include options to extend the leases for various renewal periods | ||
us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | ||
CY2020Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
60000 | |
CY2019Q2 | us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
60000 | |
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
121000 | ||
us-gaap |
Operating Lease Cost
OperatingLeaseCost
|
119000 | ||
CY2020Q2 | pbhc |
Finance Lease Cost
FinanceLeaseCost
|
20000 | |
CY2019Q2 | pbhc |
Finance Lease Cost
FinanceLeaseCost
|
12000 | |
pbhc |
Finance Lease Cost
FinanceLeaseCost
|
40000 | ||
pbhc |
Finance Lease Cost
FinanceLeaseCost
|
12000 | ||
CY2020Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
55000 | |
CY2019Q2 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
56000 | |
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
111000 | ||
us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
104000 | ||
CY2020Q2 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
20000 | |
CY2019Q2 | us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
12000 | |
us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
40000 | ||
us-gaap |
Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
|
12000 | ||
CY2020Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
17000 | |
CY2019Q2 | us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
11000 | |
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
35000 | ||
us-gaap |
Finance Lease Principal Payments
FinanceLeasePrincipalPayments
|
11000 | ||
CY2020Q2 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
583000 | |
CY2019Q4 | us-gaap |
Finance Lease Liability
FinanceLeaseLiability
|
578000 | |
CY2020Q2 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P19Y3M29D | |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P19Y6M29D | |
CY2020Q2 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P28Y11M1D | |
CY2019Q4 | us-gaap |
Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
|
P29Y5M1D | |
CY2020Q2 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0372 | |
CY2019Q4 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.0371 | |
CY2020Q2 | us-gaap |
Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
|
0.1375 | |
CY2019Q4 | us-gaap |
Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
|
0.1375 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
|
110000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
|
95000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
|
105000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
|
114000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
|
122000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
|
2624000 | |
CY2020Q2 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
3170000 |